Reply to Das and Berkhout, "How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir"

mBio. 2018 May 29;9(3):e00623-18. doi: 10.1128/mBio.00623-18.
No abstract available

Keywords: 1-LTR; 3' PPT; HIV-1; dolutegravir; integration.

Publication types

  • Letter
  • Comment

MeSH terms

  • Drug Resistance, Viral
  • HIV Infections
  • HIV Integrase Inhibitors
  • HIV-1*
  • Heterocyclic Compounds, 3-Ring*
  • Integrase Inhibitors
  • Oxazines
  • Piperazines
  • Pyridones
  • RNA

Substances

  • HIV Integrase Inhibitors
  • Heterocyclic Compounds, 3-Ring
  • Integrase Inhibitors
  • Oxazines
  • Piperazines
  • Pyridones
  • RNA
  • dolutegravir